Dry eye treatment: Vista sets a new benchmark

Vista Eye Specialist, Malaysia’s leading provider of eye care, has achieved a milestone in the treatment of dry eye disease.

A pioneering study on E>Eye Intense Regulated Pulsed Light (IRPL) therapy, spearheaded by Dr Aloysius Joseph Low and optometrist Azarina Abdullah, was recently published in the Journal of Health Science and Medical Research.

This recognition cements Vista’s reputation as an innovator in ophthalmology across Southeast Asia.

Dry eye disease is a growing global concern, exacerbated by screen-heavy lifestyles, air-conditioned environments, and ageing populations.

This chronic condition causes discomfort and affects the quality of life for millions.

Vista’s IRPL therapy offers a revolutionary solution, addressing evaporative dry eye disease caused by meibomian gland dysfunction (MGD).

A new era in dry eye care

The study, titled “The Effectiveness of E>Eye Intense Regulated Pulsed Light Therapy in Treating Evaporative Dry Eye Disease among Southeast Asian Patients,” highlights the therapy’s ability to:

• Restore gland function and stabilise tears.
• Deliver measurable improvements after just three sessions.
• Address lifestyle and environmental factors specific to Southeast Asia.

“Our mission has always been to transform lives through safe, effective, and innovative eye care solutions,” said Dr Aloysius Joseph Low. “Dry eye disease disrupts daily life and diminishes joy. With E>Eye IRPL therapy, we empower patients to reclaim their vision and their Ikigai.”

In Japanese culture, Ikigai refers to living a purposeful life. Vision plays a vital role in this, from pursuing meaningful work to enjoying personal passions. Vista’s treatments aim to do more than restore sight—they help patients reconnect with their purpose.

Partnerships driving success

This achievement underscores Vista’s partnership with ESW Vision, the global developer of the E>Eye IRPL system and Tearcheck® diagnostic unit.

Ing. Peter Baranovic, Commercial Director at ESW Vision, shared: “Collaborating with Vista brings advanced dry eye management solutions to Southeast Asia.

This partnership strengthens our shared goal of improving patient outcomes and satisfaction.”

Through evidence-based and patient-focused care, Vista sets a benchmark in Southeast Asian ophthalmology.

The clinic’s commitment to cutting-edge treatments like IRPL therapy reflects its mission to “safely help people see their best.”

As dry eye disease continues to impact lives, Vista remains steadfast in providing innovative solutions that not only restore vision but also enhance life quality, empowering patients to live with purpose and clarity.